Trial CTRI/2021/08/035648
Publication Rose W, SSRN, 2022
Primary outcome on the report: 1)Geometric mean concentration ratio (GMR) of anti-SARS-CoV-2 spike IgG between the two boosted arms in each vaccine primed group on day 28, as measured by using the MSD platform; 2)Incidence of related adverse events, serious adverse events following vaccination and any clinically significant change in the physical examination parameters and laboratory values.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.